BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6123843)

  • 1. Management of myasthenia gravis.
    Lancet; 1982 Jul; 2(8290):135-6. PubMed ID: 6123843
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis].
    Tanaka M; Nagai H; Mori S; Miyatake T; Shinada S
    No To Shinkei; 1982 Jul; 34(7):699-703. PubMed ID: 7138697
    [No Abstract]   [Full Text] [Related]  

  • 3. The immune system, Part 2: Myasthenia gravis.
    Stephens A
    Nurs Times; 1997 Nov 12-18; 93(46):56-9. PubMed ID: 9418490
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune aspects of myasthenia gravis.
    Lisak RP; Levinson AI; Zweiman B
    Concepts Immunopathol; 1985; 2():65-101. PubMed ID: 3916415
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current therapy of myasthenia].
    Zumstein V; Regli F
    Rev Med Suisse Romande; 1985 Apr; 105(4):331-8. PubMed ID: 4012144
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis: emerging new therapy options.
    Sieb JP
    Curr Opin Pharmacol; 2005 Jun; 5(3):303-7. PubMed ID: 15907918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of myasthenia gravis].
    Rilling G; Tettenborn B
    Praxis (Bern 1994); 2001 Aug; 90(33):1350-4. PubMed ID: 11534319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of myasthenia gravis].
    Szobor A; Klein M
    Psychiatr Neurol Med Psychol (Leipz); 1976 Jan; 28(1):33-42. PubMed ID: 940881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the treatment of myasthenia].
    Delwaide JP
    Rev Med Liege; 1968 Sep; 23(18):552-7. PubMed ID: 4316587
    [No Abstract]   [Full Text] [Related]  

  • 11. Opinions about plasma exchange and associated treatments in the therapy of myasthenia gravis.
    Bergamini L; Cocito D; Durelli L; Quattrocolo G
    Muscle Nerve; 1983; 6(6):457-8. PubMed ID: 6621614
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of myasthenia gravis.
    Schwendimann RN; Burton E; Minagar A
    Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis: life transforming treatments.
    Goodger E
    Nurs Mirror; 1981 Sep; 153(11):40-4. PubMed ID: 6912548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma exchange in myasthenia gravis].
    Redeker M; Meyer-Wahl L
    Nervenarzt; 1982 Dec; 53(12):729-32. PubMed ID: 7155236
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myasthenia gravis: an autoimmune theory].
    Uono M
    Nihon Rinsho; 1973 Dec; 31(12):3387-93. PubMed ID: 4598899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of therapeutic methods in myasthenia on the basis of data gathered by the Department of Neurology of the Warsaw Medical School].
    Emeryk B; Strugalska M
    Neurol Neurochir Pol; 1970; 4(3):347-54. PubMed ID: 5455384
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apropos of myasthenia gravis and its treatment].
    Leroy J; Robert M; Delaunay P; Dordain M
    Sem Hop; 1969 May; 45(24):1691-3. PubMed ID: 4308561
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of pseudoparalytic myasthenia gravis].
    Fasshauer K
    Dtsch Med Wochenschr; 1975 Oct; 100(44):2283-4. PubMed ID: 1183327
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of myasthenia gravis in children].
    Gościńska Z; Kusiak-Dadak M; Miezyński W; Petryk O; Rokosz A
    Pediatr Pol; 1972 Apr; 47(4):449-53. PubMed ID: 5022931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of myasthenia gravis].
    Gajdos P
    Presse Med; 1989 Oct; 18(35):1732-4. PubMed ID: 2531386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.